TIME-KILL STUDY OF THE IN VITRO ACTIVITY OF TIGECYCLINE AGAINST CARBAPENEM-RESISTANT KLEBSIELLA PNEUMONIAE.
- Published in:
- Thai Journal of Pharmaceutical Sciences, 2014, v. 38, p. 265
- By:
- Publication type:
- Article
Works by Koomanachai, Pornpan
Results: 16
1
2
Pharmacodynamic evaluation of tigecycline against Acinetobacter baumannii in a murine pneumonia model.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2009, v. 63, n. 5, p. 982, doi. 10.1093/jac/dkp056
- By:
- Publication type:
- Article
3
Development and Implementation of a Mobile Application for Choosing Empirical Antimicrobial Therapy for Bacteremia, Pneumonia, Urinary Tract Infection, and Skin and Soft Tissue Infection among Hospitalized Patients.
- Published in:
- Antibiotics (2079-6382), 2023, v. 12, n. 1, p. 113, doi. 10.3390/antibiotics12010113
- By:
- Publication type:
- Article
4
Implementation of Clinical Practice Guidelines for Empirical Antibiotic Therapy of Bacteremia, Urinary Tract Infection, and Pneumonia: A Multi-Center Quasi-Experimental Study.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 7, p. 903, doi. 10.3390/antibiotics11070903
- By:
- Publication type:
- Article
5
Safety and Efficacy of Ivermectin for the Prevention and Treatment of COVID-19: A Double-Blinded Randomized Placebo-Controlled Study.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 6, p. 796, doi. 10.3390/antibiotics11060796
- By:
- Publication type:
- Article
6
Impact of Antibiotic Authorisation at Three Provincial Hospitals in Thailand: Results from a Quasi-Experimental Study.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 3, p. 354, doi. 10.3390/antibiotics11030354
- By:
- Publication type:
- Article
7
Feasibility, Challenges, and Benefits of Global Antimicrobial Resistance Surveillance System Implementation: Results from a Multicenter Quasi-Experimental Study.
- Published in:
- Antibiotics (2079-6382), 2022, v. 11, n. 3, p. 348, doi. 10.3390/antibiotics11030348
- By:
- Publication type:
- Article
8
Clinical presentation, associated factors, and course of cutaneous reaction after the booster dose of COVID-19 vaccination.
- Published in:
- Clinical & Experimental Vaccine Research, 2024, v. 13, n. 4, p. 309, doi. 10.7774/cevr.2024.13.4.309
- By:
- Publication type:
- Article
9
Dialysate and plasma meropenem concentrations in continuous intraperitoneal regimen during peritoneal-dialysis-related peritonitis.
- Published in:
- PLoS ONE, 2025, v. 20, n. 1, p. 1, doi. 10.1371/journal.pone.0312160
- By:
- Publication type:
- Article
10
NOCARDIA BEIJINGENSIS BRAIN ABSCESS IN AN HIV INFECTED PATIENT: A FIRST CASE REPORT AND LITERATURE REVIEW.
- Published in:
- Southeast Asian Journal of Tropical Medicine & Public Health, 2016, v. 47, n. 5, p. 1020
- By:
- Publication type:
- Article
11
Factors Associated with Colistin-Resistant Acinetobacter baumannii Acquisition among Hospitalized Patients.
- Published in:
- Journal of the Medical Association of Thailand, 2018, v. 101, n. 8, p. 1051
- By:
- Publication type:
- Article
12
Chylous ascites and chylothorax due to constrictive pericarditis in a patient infected with HIV: a case report.
- Published in:
- 2012
- By:
- Publication type:
- journal article
13
The safety and efficacy of high versus low vancomycin trough levels in the treatment of patients with infections caused by methicillin-resistant Staphylococcus aureus: a meta-analysis.
- Published in:
- BMC Research Notes, 2016, v. 9, p. 1, doi. 10.1186/s13104-016-2252-7
- By:
- Publication type:
- Article
14
Epidemiology, clinical characteristics, and treatment outcomes of patients with COVID-19 at Thailand's university-based referral hospital.
- Published in:
- 2021
- By:
- Publication type:
- journal article
15
Population pharmacokinetic/pharmacodynamic target attainment analysis of IV fosfomycin for the treatment of MDR Gram-negative bacterial infections.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2024, v. 79, n. 6, p. 1372, doi. 10.1093/jac/dkae111
- By:
- Publication type:
- Article
16
Extracorporeal clearance of colistin methanesulphonate and formed colistin in end-stage renal disease patients receiving intermittent haemodialysis: implications for dosing.
- Published in:
- Journal of Antimicrobial Chemotherapy (JAC), 2015, v. 70, n. 6, p. 1804, doi. 10.1093/jac/dkv031
- By:
- Publication type:
- Article